Tina Stosor retweeted
Love to see the multidisciplinary care & research between @NM_IDSteward, @NMSurgery, @NM_Transplant, & @NMCardioVasc ❤️ to better understand microbiome changes, infections, & abx burden among LVAD recipients led by @TStosor @moore_wjustin #IDWeek2023
Replying to @SIDPharm
@moore_wjustin @NM_IDSteward check out the NM ID team's work on a rather uncharted territory - ASP opportunities for LVAD patients🫀🦠 (6/12) #IDWeek2023 #SIDP2023
Tina Stosor retweeted
Last but not least @littlebugdrug and @RadhikaIdpharmd present "Impact of a bundled #antimicrobialstewardship intervention leveraging frontline #pharmacist response to rapid blood culture diagnostics at an academic medical center and community hospital" #SIDP2023 #IDWeek2023 – at Boston, MA
The future of ID is in good hands with these @NM_IDSteward fellows @DrTirajeh Dani Grayer and Joshua Craft! They make us proud!@mangarone23 – at Boston, MA
Tina Stosor retweeted
Standing room only for ID treatment conundrums 🦠💊 by stacked @SIDPharm crew Drs. @ErinMcCreary @OncIDPharmd & @rebsmoe #IDWeek2023
Erin schooling us all on Cefazolin CNS & brain tissue concentrations 🧠🤯. Check out the paper for more info: academic.oup.com/cid/advance…
Tina Stosor retweeted
Just moderated a great @IDWeekmtg session with @costisifri on Complex COVID Management Issues in Special Populations with two amazing faculty: @TStosor and Veronica Dioverti. Check out the recording!
Tina Stosor retweeted
Thanks @accpinfdprn! Owe so much to this group for providing mentors, friends, & resources over the years. If any trainees or early career clinicians are looking for an ID pharmacist network be sure to check out @accpinfdprn & @SIDPharm 💙
Congratulations to Dr. Justin Moore for being nominated as the ACCP ID PRN Member Spotlight! 🤩🤩
Be sure to check your inbox for the latest edition of the ID PRN Newsletter & to read more about Dr. Moore’s practice. 📨🤓
#IDTwitter #IDX #IDPRN
Tina Stosor retweeted
We're thrilled to announce that Abby Agarwal, MD, has been named the Medical Director of the Living Donor Kidney Transplant Program. Congratulations, Dr. Agarwal!
Tina Stosor retweeted
Great @NorthwesternMed ID Adult-Peds Joint Conference today with @LuriePedsID presented by Adult ID Fellow Dr. @SaraHockney, walking us through a recent Babesia case 💊 – at Chicago, IL
Tina Stosor retweeted
Great opportunity to train in a robust transplant program with a wide range of clinical exposure and research. Take a look! – at Chicago, IL
Calling all applicants!
Applications for the Transplant Nephrology Fellowship are now live! This fellowship provides trainees the opportunity to gain knowledge, procedural skills and more to become a highly qualified transplant nephrologists. To apply, email [email protected]
Tina Stosor retweeted
It was an honour to be mentored by you! I am also thankful for the incredible team @NM_IDSteward who brings the best out of you! Special thanks to @SajalTanna @mangarone23 @TStosor who helped me grow clinically. @moore_wjustin for all the guidance in my stewardship training.
Tina Stosor retweeted
#mpox resurgence in Chicago this summer?
"This gives us pause that vaccine immunity may not be lasting long in some patients despite full vaccination." — @NUFeinbergMed's Dr. Alex Carvalho. @HultquistLab @NM_IDSteward @TStosor news.northwestern.edu/storie…
Tina Stosor retweeted
Help with donations for the @NUFeinbergMed chapter of Chicago Street Medicine. @NU_IntMed @NM_IDSteward
amazon.com/registries/custom…
Tina Stosor retweeted
How to approach MDRO in tx/VAD pts? VAD ok if not septic, concern for B cenosepacia , consider prolonged combination rx +/-phage, watch out for CRE/CRAB, consider ppx vanc if recent C diff ! Fernanda Silveira citing data fr @TStosor @judithanesi @StephaniePouch #ISHLT2023
Tina Stosor retweeted
Want to get involved with @ishlt if you’re early in your career? @RAKlingbeilDNP has some great points!
✅ Get engaged with your PC! It’s a great starting point
✅ Add peeps on SoMe
✅ Volunteer to review abstracts next year for ISHLT2024!
Tina Stosor retweeted
Approach to COVID+ donors- start with making sure your candidates are up to date on their vaccination following latest @CDCgov guidelines- and counsel pt to accept given data of safety and risk of death on waitlist @rebecca_kumar @KiranKhush1 @RicardoLaHozMD #ISHLT2023
Tina Stosor retweeted
Replying to @RicardoLaHozMD
@RicardoLaHozMD presents his work on a Phase 3 trial of maribavir vs investigator-assigned therapy for cytomegalovirus (CMV) infection. @ISHLT #ISHLT2023 @UTSWInfDis @utswheart @UTSWCardfellow
































